Christmas holidays are associated with a mild and reversible deterioration in glucose metrics among individuals w/ T1D using flash continuous glucose monitoring, irrespective of additional influencing factors. Read more: endocrinepractice.org/article/S1530-… #endotwitter Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD

We will be bringing all the charms of New Orleans right to the heart of the AACE Annual Meeting with Café du Monde's iconic beignets and coffee, served right here at #AACE2024 . Don't miss this exclusive pop-up experience. Register today: pro.aace.com/events/2024/an… #endotwitter

Congratulations to the 2024 AACE Award recipients! Together, #WeAreAACE . Read more about each winner: pro.aace.com/about/awards/2… #endotwitter

With counseling and early referral to pediatric urology, a high percentage of fertility preservation in transgender girls was achieved. Read more: endocrinepractice.org/article/S1530-… #endotwitter Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD

AACE is the trusted source for high-caliber #endocrinology education for all care team members. Register for #AACE2024 today: pro.aace.com/events/2024/an… #endotwitter

This week I sent my first CEO message to our members and community. Its the first of many communications, and I'm excited about the opportunity to keep Endocrinologists and other healthcare professionals informed about the activities of the AACE

pro.aace.com/recent-news-an…

Honored to chair the inaugural AACE MENA Cardiometabolic Conference. Many thanks to the advisory board, world expert speakers, AACE President Dr. Susan Samson and CEO Johnnie White, CEO for making this a success!

Benefits of parathyroidectomy for bone were found to include significant percent increases in LS, FN, and TH BMD up to the third year after surgery. Read more: endocrinepractice.org/article/S1530-… Vin Tangpricha, MD, PhD Elsevier Endocrinology & Diabetes #endotwitter

Another exciting day of knowledge and inspiration, Day 2 of #AACEMENA has been incredible so far! Are you enjoying it as much as we are? 🌟

#endotwitter #endocrinology #diabetes #medicine #medicalconference #conference #medicalevents

Join the ongoing session led by Dr. Khalid Al Rasadi on advances in lipidology. Discover the latest in new and emerging therapies.

#AACEMENA

Discover the intriguing session led by Dr. Connie Rhee on Slowing the Progression of Diabetic Nephropathy. Head over to Hall A now to join!
Connie Rhee

#AACEMENA

✨Concluding the AACE MENA Cardiometabolic Conference, we have Prof. Jaime Almandoz, our esteemed chair, delivering the closing plenary.

Jaime Almandoz, MD MBA FTOS

#AACEMENA

More than 4 in 10 U.S. adults have obesity. Some of them are your patients. Support their path forward with the new AACE Journey for Patients With Obesity. Available now: aace.com/patient-journe… #endotwitter

Join thousands of experts from the field of #endocrinology in the vibrant city of New Orleans to convene, collaborate, and learn together. Register for #AACE2024 : pro.aace.com/events/2024/an… #endotwitter

Join AACE for a virtual presentation at NPACE on June 7, 2024 – 11:15 AM -12:15 P.M. EST to uncover the complete spectrum of obesity management in our groundbreaking program: pro.aace.com/education-and-… #endotwitter

Exciting kick-off at our inaugural AACE MENA Cardiometabolic Conference in Abu Dhabi! Day 1 delved into crucial discussions on obesity, cardiometabolic risks, and beyond. #WeAreAACE #AACEMENA #CardiometabolicConference

Point/Counterpoint: SGLT-2 Inhibitor Use. The objective of this counterpoint piece is to highlight areas of benefit for starting or continuing SGLT-2 inhibitors in the inpatient setting. Read more: endocrinepractice.org/article/S1530-… #endotwitter Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD

The AACE Patient Journey of Diabetes Technology is now available! Get the latest information on a wide range of devices and technologies that can be used to meet blood sugar goals and manage #diabetes . Learn more: aace.com/patient-journe… #endotwitter

Point/Counterpoint: SGLT-2 Inhibitor Use. This article describes the risks associated with the use of SGLT2i for the management of inpatient hyperglycemia: endocrinepractice.org/article/S1530-… #endotwitter Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD

Managing thyroid disease can be challenging and confusing. Use the Thyroid Patient Journey to navigate your thyroid condition. Each step of the journey covers a different part of part of your thyroid disease experience. Learn more: aace.com/patient-journe… #endotwitter